Donald C. Manning

Insider

First SEC filing: June 4, 2020 · Latest: June 4, 2020

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

4 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
June 9, 2021	PCRX	A	6,000	—	—	29,520 Direct	+25.51%	Acquired	(price as of 2026-08-20)
June 9, 2021	PCRX	A	15,000	—	—	15,000 Direct	—	Acquired	(price as of 2026-08-20)
June 8, 2021	PCRX	S	2,600	$61.14	$158,964	23,520 Direct	-9.95%	Disposed	-60.6% (price as of 2026-08-20)
June 2, 2021	PCRX	S	2,380	$62.12	$147,846	26,120 Direct	-8.35%	Disposed	-61.2% (price as of 2026-08-20)
June 2, 2020	PCRX	A	71,300	—	—	71,300 Direct	—	Acquired	(price as of 2026-08-20)
June 2, 2020	PCRX	A	28,500	—	—	28,500 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
June 9, 2021	PCRX	Stock Option (Right to Buy)	Common Stock (15,000)	$60.96	June 9, 2031	15,000	Acquired
June 2, 2020	PCRX	Stock Option (Right to Buy)	Common Stock (71,300)	$43.58	June 2, 2030	71,300	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).